Name	Quantity	Component
Test card	25	It is composed of fluorescent pad (coated with fluorescent labeled N-terminal prohormone of brain natriuretic peptide (NT-proBNP) monoclonal mouse antibody), nitrocellulose membrane (coated with N-terminal prohormone of brain natriuretic peptide (NT-proBNP) monoclonal mouse antibody and Goat anti mouse IgG antibody), absorbent paper and backing
Sample buffer	25(300μL/tube)	Phosphate buffer
ID card	1	Record the standard curve information of this kit

Assay list
Cardiac
cat#.	Product item	Specimen	Reaction Time	Measure Range	Clinical Range	Itended Use
1	cTnI	WB/Serum/Plasma	12min.	0.1-40ng/ml	<0.3ng/ml	several heart diseases including myocardial infarction and heart failure.
2	Myo	WB/Serum/Plasma	12min.	5-400ng/ml	<58ng/ml	acute myocardial infarction (AMI) in early stage.
3	CK-MB	WB/Serum/Plasma	12min.	1-200ng/ml	<5ng/ml	acute myocardial infarction (AMI) in early stage.
4	NT-proBNP	WB/Serum/Plasma	10min.	20-35000pg/ml	Under 75:0~347pg/mL, Over 75:0~449pg/mL	heart failure .
5	D-Dimer	WB/Plasma	10min.	40-10000ng/ml	<500ng/ml	disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
6	cTnI+Myo+CKMB	WB/Serum/Plasma	12min.	same with single item	same with single item	Triple marker of myocardial infarction.
7	ST2	WB/Serum/Plasma	10min.	10-400ng/ml	<35ng/ml	heart failure .
8	Lp-PLA2	WB/Serum/Plasma	10min.	10-900ng/ml	<175ng/ml	Risk evaluation of ACS and atherosclerotic ischemic stroke patients.
9	S100-β	WB/Serum/Plasma	10min.	0.05-10ng/ml	<0.2ng/ml	Cerebral infarction, cerebral injury.
Inflammation
10	CRP / hs-CRP	WB/Serum/Plasma	3min.	0.5-200mg/L	CRP<10mg/L,hs-CRP<1mg/L	nonspecficity inflammatory marker.
11	SAA	Serum	5min.	1-200mg/L	<10mg/L	inflammation&infection.
12	PCT	WB/Serum/Plasma	10min.	0.2-100ng/ml	<0.5ng/ml	Sepsis
13	CRP+SAA	WB/Serum/Plasma	5min.	same with single item	same with single item	inflammation&infection.
14	IL-6	WB/Serum/Plasma	10min.	5-4000pg/ml	10pg/ml	diabetes,rheumatoid arthritis,etc
Thyroid Hormone
15	TSH	Serum/Plasma	15min.	0.3-100mU/L	0.35-5mU/L	hyperthyroidism and hypothyroidism
16	TT3	Serum/Plasma	15min.	0.5-10nmol/L	1.3-3.1nmol/L	thyroid dysfunction
17	TT4	Serum/Plasma	15min.	5-300nmol/L	66-181nmol/L	thyroid dysfunction
18	FT3	Serum/Plasma	15min.	1-100pmol/L	4-10pmol/L	thyroid dysfunction
19	FT4	Serum/Plasma	15min.	5-300pmol/L	19-39pmol/L	thyroid dysfunction
Tumor Marker
20	AFP	Serum/Plasma	15min.	2.5-200ng/ml	<20ng/ml	pregnancy cancer
21	CEA	Serum/Plasma	15min.	1-200ng/ml	<5ng/ml	colon cancer, colorectal cancer,etc.
22	NSE	Serum/Plasma	15min.	1-400ng/ml	<16ng/ml	non-small cell lung cancer
23	FOB	fecal specimens	10min.	50-1000ng/ml	<100ng/ml	Abnormal recessive gastrointestinal bleeding
24	PG II	Serum/Plasma	15min.	1-100ug/L	PGI/PGII>3.0	gastric abnormalities
25	PG I	Serum/Plasma	15min.	2.5-200ug/L	>70ng/ml	gastric abnormalities
26	TPSA	Serum/Plasma	15min.	0.5-40ng/ml	<4ng/ml	prostate cancer
27	FPSA	Serum/Plasma	15min.	0.1-10ng/ml	<1ng/ml	prostate cancer
28	CA12-5	Serum/Plasma	15min.	20-500U/ml	<35U/ml	ovarian cancer
29	CA15-3	Serum/Plasma	15min.	10-400U/ml	< 25 U/mL	breast cancer
30	HE4	Serum/Plasma	15min.	50-2000pmol/L	<140 pmol/L	ovarian cancer
31	CA19-9	Serum/Plasma	15min.	10-400U/ml	< 27 U/mL	pancreatic cancer
32	β-HCG	Serum/Plasma	15min.	5-400mIU/ml	<10 mIU/mL	Early pregrancy, ectopic HCG cancer,incomplete abortion
33	CK19(Cyfra21-1)	Serum/Plasma	15min.	0.5-50ng/ml	<2.5ng/ml	non-small cell lung cancer
Fertility
34	HCG / β-HCG	Serum/Plasma	10min.	5-20000mIU/ml	<5 mIU/mL	early pregrancy.
35	AMH	Serum/Plasma	10min.	0.1-16ng/ml	Male: 20-60 years old, 0.92-13.89 ng/mL Female: 20-29 years old, 0.88-10.35 ng/mL 30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL	ovarian reserve level
Gastrointestinal
36	FOB	fecal specimens	10min.	qualitative	qualitative	gastrointestinal hemorrhage.
37	TRF	fecal specimens	10min.	qualitative	qualitative	gastrointestinal hemorrhage.
38	FOB+TRF	fecal specimens	10min.	qualitative	qualitative	gastrointestinal hemorrhage.
Infection
39	C.Pneumonia	WB/Serum/Plasma	15min.	qualitative	qualitative	CP infection
40	M.Pneumonia	WB/Serum/Plasma	15min.	qualitative	qualitative	MP infection
41	Covid-19 Antigen	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
42	Covid-19 Ab IgG/IgM	WB/Serum/Plasma	15min.	qualitative	qualitative	respiratory tract
43	FluA	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
44	FluB	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
Renal Injury
45	CysC	WB/Serum/Plasma	5min.	0.4-9mg/L	0.5-1.1mg/L	renal function
46	NGAL	Urine	10min.	10-1500ng/mL	<132ng/mL	acute kidney injury.
Other
47	FERR	Serum	5min.	10-500ng/ml	Male:24ng/mL~335ng/mL, Female:11ng/mL~307ng/mL	iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
48	HbA1c	WB	10min.	4%-14%	4%-6%	diabetes
49	VD	Serum/Plasma	15min.	8-70ng/mL	19-57ng/mL	fetation

POCT Cardiac Testing Kit N-Terminal Prohormone Of Brain Natriuretic Peptide For Clinical

CE POCT Cardiac Testing Kit

Cassette NT-proBNP Cardiac Testing Kit

Clinical NT-proBNP Rapid Test Kit

S100-β Cardiac Testing Kit FIA POCT 20T Package High Accuracy CE Approval

D-Dimer Rapid Test Kit IFA Colloidal Gold IVD Blood Diagnostic kit

FIA POCT Cardiac Testing Kit NT-proBNP For Clinical Detection CE Approval

Cardiac Diagnostic Lp-PLA2 Rapid Test Kit 5000 Tests/Day for Physical Examination Center

D-Dimer Cardiac Testing Kit

FIA Cardiac Testing Kit

Lp-PLA2 Rapid Test Kit